Hematology/Oncology

Top Story

FDA grants orphan drug designation to BPM31510 for pancreatic cancer

January 23, 2018
Meeting News

Pembrolizumab induces durable responses in advanced liver cancer

January 23, 2018
Pembrolizumab treatment led to durable OS and PFS among patients with advanced hepatocellular carcinoma who previously progressed on sorafenib, according to results of…
In the Journals PlusPerspective

Stem cell transplant maintains benefit for multiple myeloma in era of novel agents

January 23, 2018
Treatment with high-dose melphalan followed by autologous hematopoietic stem cell transplant conferred longer PFS with minimal toxic effects compared with novel agents…

CHIP funding renewed for 6 years

January 23, 2018
After 4 months without a permanent solution for funding, the Children’s Health Insurance Program received monetary support for the next 6 years on Monday, Jan…

Lymphadenectomy may not add benefit in high-risk renal cell carcinoma

January 23, 2018
Patients with high-risk renal cell carcinoma who undergo surgery may not benefit from lymphadenectomy, according to a secondary analysis of the randomized ASSURE…
More Headlines »
CME ABIM MOC

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent…
More »
Video
Meeting News

VIDEO: Ipilimumab-nivolumab emerges as new standard for metastatic renal cell carcinoma

November 15, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium

CME ABIM MOC

Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago

There is no commercial support for this activity.

This CME case study will discuss the treatment of polycythemia rubra vera.
More »
Current Issues
View the Current Issue
HemOnc Today